Manufacturer VerifiedChina

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

Pien Tze Huang

Pien Tze Huang Pharmaceutical is a premium traditional Chinese medicine manufacturer headquartered in Zhangzhou, Fujian, China, founded in 1956 with secret formula origins dating to the Ming Dynasty. The company achieved annual revenue of CNY 9.00 billion, with its flagship hepatoprotective product commanding extraordinary pricing power as a luxury medicinal brand. Pien Tze Huang operates under state-protected secret formula status, controlling a unique production chain for one of China's most valuable TCM brands. The company employs approximately 3,000 staff and has secured a landmark import license for Argentine natural bezoar, breaking its historical raw material bottleneck.

Strengths: Exclusive state-protected secret formula creates an unbreachable competitive moat; breakthrough import license for Argentine natural bezoar (valid until 2027) resolves historic supply constraint; premium brand positioning with luxury gift economy status drives extraordinary per-unit margins; successful diversification into TCM cosmetics and health supplements (Blue Hat series up 110%); 582 physical TCM clinic locations creating integrated healthcare ecosystem.
Weaknesses: 2025 revenue declined 16.56% and net profit fell 27.49% — first dual decline since 2003 IPO; core hepatoprotective product inventory surged 265.53% due to raw material cost timing mismatch; extreme dependency on limited natural resource inputs (bezoar, musk) creates structural supply risk; limited production scalability compared to high-volume generic manufacturers.

Core Business Areas

Hepatoprotective & Liver Care Products — Core Business
• Pien Tze Huang tablets/capsules state secret formula
• Various liver health proprietary formulations

Traditional Chinese Patent Medicines
• Anti-inflammatory and detoxification formulas
• Cardiovascular and metabolic health products

TCM Cosmetics & Personal Care
• Premium skincare leveraging TCM active ingredients
• Pearl-based and herbal beauty product lines

Health Supplements Blue Hat
• Functional food products with approved health claims
• Wellness and immunity support formulations

Industry Rankings

9Top 10 Traditional Chinese Medicine Manufacturers & Suppliers

Mfr

Corporate Report

Pien Tze Huang Pharmaceutical is a China-based premium TCM manufacturer headquartered in Zhangzhou, Fujian. Founded in 1956 with a secret formula heritage tracing back to the Ming Dynasty, the company is protected under China's highest-level trade secret designation. With 2025 revenue of CNY 9.00 billion, Pien Tze Huang represents the ultimate luxury brand in Chinese medicine, employing approximately 3,000 staff at its specialized manufacturing facilities in Fujian province.

Core Business

Pien Tze Huang's core competency lies in its eponymous hepatoprotective product — a state-protected secret formula combining natural musk, bezoar, and other precious ingredients in a proprietary manufacturing process. Beyond its flagship liver care product, the company has successfully diversified into premium TCM cosmetics, functional health supplements, and operates an expanding network of 582 physical TCM clinics. Its recent breakthrough in securing Argentine natural bezoar import rights represents a strategic masterstroke in supply chain diversification.

Key Strengths

1. Irreplaceable competitive moat from China's highest-level state-protected secret formula. 2. Extraordinary brand value as both medicine and luxury gift — often called the "Moutai of Medicine." 3. Strategic breakthrough in international raw material sourcing (Argentine bezoar import license). 4. Successful brand extension into high-margin TCM cosmetics and supplements segments. 5. Growing healthcare ecosystem with 582 physical clinic locations integrating products and services.

Challenges & Outlook

2025 marked a historic inflection point: the first simultaneous revenue (-16.56%) and net profit (-27.49%) decline since its 2003 IPO. The root cause was a devastating raw material cost timing mismatch — settling 2024's peak-price bezoar inventory through 2025 production cycles. Core product inventory exploded 265.53%, and operating cash flow collapsed 94.14%. However, with bezoar prices normalized and import channels opened, 2026 should see significant margin recovery. VerityRank Score of 85/100 acknowledges the unparalleled brand moat while reflecting the current cyclical headwinds.

VerityRank Score

85/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

China

Founded

1956

Employees

3000

Factories

Core secret-formula manufacturing base in Zhangzhou, Fujian. Limited production capacity constrained by natural musk and bezoar quotas.

Listing

SHA: 600436

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , Pien Tze Huang 2025 Annual Report Analysis, Pien Tze Huang Revenue & Profit Decline, Pien Tze Huang Official Website, Wikipedia — Pien Tze Huang

Back to Rankings